Recent Finacing
Recent Raise
NeuroTherapia is a Cleveland-based clinical-stage biotech developing oral small-molecule cannabinoid receptor agonists (lead NTRX-07) to inhibit microglia-mediated neuroinflammation in Alzheimer’s, Parkinson’s, and ALS, conducting first-in-human trials.
